Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung

Clinical Cancer Research

Volumn 8, Issue 10, 2002, Pages 3046-3053

  Seki, Nobuhiko ^a   Takasu, Tasaburo ^b   Mandai, Koichi ^a   Nakata, Masao ^a   Saeki, Hideyuki ^a   Heike, Yuji ^a   Takata, Ichiro ^a   Segawa, Yoshihiko ^a   Hanafusa, Toshiaki ^b   Eguchi, Kenji ^c  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STROMA; TUMOR; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; ADENOMA; AGED; BLOTTING, WESTERN; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 0036796009     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Travis, W. D., Travis, L. B., and Devesa, S. S. Lung cancer. Cancer (Phila.), 75: 191-202, 1995.
2. Travis, W. D., Colby, T. V., Corrin, B., Shimosato, Y., and Brambilla, E. in collaboration with Sobin, L. H., and pathologists from 14 countries. Histological Typing of Lung and Pleural Tumors, Ed. 3. Berlin: Springer-Verlag, 1999.
3. Miller, R. R. Bronchioloalveolar cell adenomas. Am. J. Surg. Pathol., 14: 904-912, 1990.
4. Kitamura, H., Kameda, Y., Ito, T., and Hayashi, H. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am. J. Clin. Pathol., 111: 610-622, 1999.
5. Kerr, K. M. Pulmonary preinvasive neoplasia. J. Clin. Pathol. (Lond.), 54: 257-271, 2001.
6. Chapman, A. D., and Kerr, K. M. The association between atypical adenomatous hyperplasia and primary lung cancer. Br. J. Cancer, 83: 632-636, 2000.
7. Mori, M., Rao, S. K., Popper, H. H., Cagle, P. T., and Fraire, A. E. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung. Mod. Pathol., 14: 72-84, 2001.
8. Niho, S., Yokose, T., Suzuki, K., Kodama, T., Nishiwaki, Y., and Mukai, K. Monoclonality of atypical adenomatous hyperplasia of the lung. Am. J. Pathol., 154: 249-254, 1999.
9. Slebos, R. J., Baas, I. O., Clement, M. J., Offerhaus, G. J., Askin, F. B., Hruban, R. H., and Westra, W. H. p53 alterations in atypical alveolar hyperplasia of the human lung. Hum. Pathol., 29: 801-808, 1998.
10. Westra, W. H., Baas, I. O., Hruban, R. H., Askin, F. B., Wilson, K., Offerhaus, G. J., and Slebos, R. J. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res., 56: 2224-2228, 1996.
11. Kitamura, H., Kameda, Y., Ito, T., Hayashi, H., Nakamura, N., Nakatani, Y., Inayama, Y., and Kanisawa, M. Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies. Virchows Arch., 431: 415-424, 1997.
12. Suzuki, K., Ogura, T., Yokose, T., Nagai, K., Mukai, K., Kodama, T., Nishiwaki, Y., and Esumi, H. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int. J. Cancer, 79: 384-389, 1998.
13. Hershey, J. W. Translational control in mammalian cells. Annu. Rev. Biochem., 60: 717-755, 1991.
14. Gallie, D. R. A tale of two termini: a functional interaction between the termini of an mRNA is a prerequisite for efficient translation initiation. Gene (Amst.), 216: 1-11, 1998.
15. Clemens, M. J., and Bommer, U. A. Translational control: the cancer connection. Int. J. Biochem. Cell Biol., 31: 1-23, 1999.
16. Raught, B., and Gingras, A. C. eIF4E activity is regulated at multiple levels. Int. J. Biochem. Cell Biol., 31: 43-57, 1999.
17. Lazaris-Karatzas, A., Montine, K. S., and Sonenberg, N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature (Lond.), 345: 544-547, 1990.
18. De Benedetti, A., and Rhoads, R. E. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc. Natl. Acad. Sci. USA, 87: 8212-8216, 1990.
19. Polunovsky, V. A., Rosenwald, I. B., Tan, A. T., White, J., Chiang, L., Sonenberg, N., and Bitterman, P. B. Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol. Cell. Biol., 16: 6573-6581, 1996.
20. Kevil, C. G., De Benedetti, A., Payne, D. K., Coe, L. L., Laroux, F. S., and Alexander, J. S. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int. J. Cancer, 65: 785-790, 1996.
21. Shatkin, A. J. Capping of eucaryotic mRNAs. Cell, 9: 645-653, 1976.
22. Duncan, R., Milburn, S. C., and Hershey, J. W. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J. Biol. Chem., 262: 380-388, 1987.
23. Hiremath, L. S., Webb, N. R., and Rhoads, R. E. Immunological detection of the messenger RNA cap-binding protein. J. Biol. Chem., 260: 7843-7849, 1985.
24. Rhoads, R. E., Joshi-Barve, S., and Rinker-Schaeffer, C. Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis. Prog. Nucleic Acid Res. Mol. Biol., 46: 183-219, 1993.
25. De Benedetti, A., and Harris, A. L. eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol., 31: 59-72, 1999.
26. Zimmer, S. G., De Benedetti, A., and Graff, J. R. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion, and metastasis. Anticancer Res., 20: 1343-1351, 2000.
27. Nathan, C. A., Carter, P., Liu, L., Li, B. D., Abreo, F., Tudor, A., Zimmer, S. G., and De Benedetti, A. Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene, 15: 1087-1094, 1997.
28. Graff, J. R., Boghaert, E. R., De Benedetti, A., Tudor, D. L., Zimmer, C. C., Chan, S. K., and Zimmer, S. G. Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts. Int. J. Cancer, 60: 255-263, 1995.
29. Miyagi, Y., Sugiyama, A., Asai, A., Okazaki, T., Kuchino, Y., and Kerr, S. J. Elevated levels of eukaryotic translation initiation factor eIF-4E, mRNA in a broad spectrum of transformed cell lines. Cancer Lett., 91: 247-252, 1995.
30. Kerekatte, V., Smiley, K., Hu, B., Smith, A., Gelder, F., and De Benedetti, A. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int. J. Cancer, 64: 27-31, 1995.
31. Li, B. D., Liu, L., Dawson, M., and De Benedetti, A. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma. Cancer (Phila.), 79: 2385-2390, 1997.
32. Li, B. D., McDonald, J. C., Nassar, R., and De Benedetti, A. Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression. Ann. Surg., 227: 756-761, 1998.
33. Crew, J. P., Fuggle, S., Bicknell, R., Cranston, D. W., de Benedetti, A., and Harris, A. L. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression. Br. J. Cancer, 82: 161-166, 2000.
34. Rosenwald, I. B., Chen, J. J., Wang, S., Savas, L., London, I. M., and Pullman, J. Up-regulation of protein synthesis initiation factor eIF4E is an early event during colon carcinogenesis. Oncogene, 18: 2507-2517, 1999.
35. Berkel, H. J., Turbat-Herrera, E. A., Shi, R., and de Benedetti, A. Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon. Cancer Epidemiol. Biomark. Prev., 10: 663-666, 2001.
36. Nathan, C. A., Liu, L., Li, B. D., Abreo, F. W., Nandy, I., and De Benedetti, A. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene, 15: 579-584, 1997.
37. Nathan, C. A., Sanders, K., Abreo, F. W., Nassar, R., and Glass, J. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res., 60: 3599-3604, 2000.
38. Rosenwald, I. B., Hutzler, M. J., Wang, S., Savas, L., and Fraire, A. E. Expression of eukaryotic translation initiation factors 4E and 2α is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung. Cancer (Phila.), 92: 2164-2171, 2001.
39. Ferguson, M. K., DeMeester, T. R., DesLauriers, J., Little, A. G., Piraux, M., and Golomb, H. Diagnosis and management of synchronous lung cancers. J. Thorac. Cardiovasc. Surg., 89: 378-385, 1985.
40. Okada, M., Tsubota, N., Yoshimura, M., and Miyamoto Y. Operative approach for multiple primary lung carcinomas. J. Thorac. Cardiovasc. Surg., 115: 836-840, 1998.
41. Takasu, T., Lyons, J. C., Park, H. J., and Song, C. W. Apoptosis and perturbation of cell cycle progression in an acidic environment after hyperthermia. Cancer Res., 58: 2504-2508, 1998.
42. Higashiyama, M., Kodama, K., Yokouchi, H., Takami, K., Mano, M., Kido, S., and Kuriyama, K. Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma. Ann. Thorac. Surg., 68: 2069-2073, 1999.
43. Carretta, A., Canneto, B., Calori, G., Ceresoli, G. L., Campagnoli, E., Arrigoni, G., Vagani, A., and Zannini, P. Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma. Eur. J. Cardiothorac. Surg., 20: 367-371, 2001.
44. Koga, T., Hashimoto, S., Sugio, K., Yoshino, I., Mojtahedzadeh, S., Matsuo, Y., Yonemitsu, Y., Sugimachi, K., and Sueishi, K. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma. Clin. Cancer Res., 7: 1730-1738, 2001.
45. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
46. Elenbaas, B., and Weinberg, R. A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res., 264: 169-184, 2001.
47. Sorrells, D. L., Meschonat, C., Black, D., and Li, B. D. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor. J. Surg. Res., 85: 37-42, 1999.
48. Rousseau, D., Gingras, A. C., Pause, A., and Sonenberg, N. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene, 13: 2415-2420, 1996.
49. Hidalgo, M., and Rowinsky, E. K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene, 19: 6680-6686, 2000.
50. Hidalgo, M., Rowinsky, E., Erlichman, C., Drengler, R., Marshall, B., Adjei, A., Hammond, L., Speicher, L., Galanis, E., Edwards, T., Boni, J., Dukart, G., Buckner, J., and Tolcher, A. A Rapamycin analog and multifaceted inhibitor of signal transduction: a Phase I study. Proc. Am. Soc. Clin. Oncol. Annu. Meet., 19: 187, 2000.
51. Raymond, E., Alexandre, J., Depenbrock, H., Mekhaldi, S., Angevin, E., Hanauske, A., Baudin, E., Escudier, B., Frisch, J., Boni, J., and Armand, J. A Rapamycin analog with antitumor activity: a Phase I study utilizing a weekly schedule. Proc. Am. Soc. Clin. Oncol. Annu. Meet., 19: 187, 2000.